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ABSTRACT
Autoimmune disorders such as rheumatoid arthritis or Sjo¨gren’s syndrome can be associated with impaired renal acid
excretion. Only few cases of patients with primary biliary cirrhosis (PBC) and distal renal tubular acidosis (dRTA) have been
described. Here, we present the case of a 60-year-old woman with PBC and dRTA. Her kidney biopsy showed an absence of
markers of acid-secretory Type A intercalated cells (A-ICs) and expression of aquaporin-2, a marker of principal cells, in all
cells lining the collecting duct. Moreover, the serum of the patient contained antibodies directed against a subset of cells of
the collecting duct. Thus, PBC-related autoantibodies may target acid-secretory A-ICs and thereby impair urinary
acidification.
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INTRODUCTION
Renal tubular acidosis (RTA) is caused by impaired ability of the
kidney either to regenerate bicarbonate from ammoniagenesis
or to excrete acids and increase urinary acidification. The latter
function can be disturbed in syndromes of distal renal tubular
acidosis (dRTA). Type I RTA or dRTA can be caused by inherited
mutations in genes encoding the anion exchanger 1 (AE1) anion
exchanger (SLC4A1), the a4 and B1 Hþ-ATPase subunits
(ATP6V0a4 and ATP6V1B1) or the forkhead transcription factor
(Figure 1) [1–2]. Acquired forms of dRTA can be due to various
drugs or are often observed as part of the various autoimmune
disorders including Sjo¨gren’s syndrome, rheumatoid arthritis
and possibly also primary biliary cirrhosis (PBC). In biopsies of
some of these patients, the absence of Hþ-ATPase staining in
the collecting duct was reported [3–7].
Here, we report the case of a 60-year-old female patient with
PBC and dRTA and the absence of markers of intercalated cells
in her kidney biopsy. To our knowledge, this is the first case of
PBC with dRTA and with a detailed analysis of the kidney
biopsy.
CLINICAL CASE
A 60-year-old woman was admitted because of progressive
chronic kidney disease. On admission, she had a creatinine of
171 mmol/L [estimated glomerular filtration rate of 28 mL/min/
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1.73 m2 (CKD-EPI)] and microalbuminuria. The urine dipstick
was positive for leucocytes but not for erythrocytes. Her urinary
sediment was normal, as was her physical examination. There
were no signs of a systemic disease and no oedema.
Her past medical history was unremarkable apart from hy-
pertension, for which she was taking amlodipine, and PBC. The
latter was treated with ursodeoxycholic acid and enterically
coated with budesonide. She tested negative for antinuclear
antibodies, anti-neutrophil cytoplasmic antibodies, rheumatoid
factor and antibodies against SS-A and SS-B. IgM antibodies
were slightly elevated (5.72 g/L, normal range: 0.4–2.4 g/L), anti-
mitochondrial antibody (AMA) titres were >2560 (normal <80).
A renal biopsy showed active tubulointerstitial nephritis and
signs of hypertensive renal disease (Figure 2).
Blood gas analysis was performed. Her pH was 7.23 with bi-
carbonate of 11.1 mmol/L and a pCO2 of 27.5 mmHg. Her
anion gap was normal with a value of 11.9 mmol/L (Naþ
140 mmol/L, Kþ 3.3 mmol/L, Cl 117 mmol/L). Taken together,
these data indicate a normal anion gap metabolic acidosis and
hypokalaemia.
Her urinary pH was 7.0, urinary-specific gravity was 1.005 g/
mL and the urinary anion gap (UAG) was positive (UAG ¼ UNa þ
UK  UCl ¼ 55 mmol/Lþ 18.5 mmol/L  41 mmol/L¼ 32.5 mmol/L).
We concluded that our patient had dRTA. The patient did not
have diarrhoea, and there was no evidence for the use of laxatives.
The association of PBC and RTA has been described before
[8–14] and one study [15] also speculated about the pathophysi-
ology of the RTA.
Kidney biopsy sections were stained with antibodies
against the AE1 [16], in kidney specifically expressed in acid-
secretory type A intercalated cells (A-ICs) (Figures 1 and 2) (for
methods see Supplementary information). It is also expressed
in red blood cells. Sections were co-stained with antibodies
against the B1 Hþ-ATPase subunit [17] (also highly enriched in
A-ICs) and against the AQP2 water channel expressed in
neighbouring principal cells (PCs) (Figures 1 and 2). While
strong staining for AE1 and the B1 Hþ-ATPase subunit was
found in cells of the collecting duct system in biopsies from
healthy control kidneys (n¼ 4 independent kidneys), no stain-
ing was detectable in the patients biopsy. Of note, AE1 still
stained red blood cells present in the biopsy (Figure 3A and
B). In another set of biopsies stained for the a4 Hþ-ATPase
subunit [18], enriched in all subtypes of ICs, and for the AQP2
water channel, no staining for a4 in cells of the collecting
duct system was detectable, whereas all cells were positive
for AQP2 (Figure 3C and D).
FIGURE 1: Scheme depicting the different types of cells in the collecting duct and their specific markers. PCs express the AQP2 water channel together with the ENaC
Naþ- and ROMK (Renal Outer Medullary Kþ-channel) Kþ-channel. Acid-secretory A-ICs express the basolateral AE1 and luminal Hþ-ATPases containing the B1 and a4
subunits. Bicarbonate-secretory Type B and non-A/non-B intercalated cells (B-IC and non-A/non-B-IC) express pendrin (Pds) and the Naþ-dependent bicarbonate-chlo-
ride exchanger (NDBCE), and either basolateral (B-IC) or luminal (non-A/non-B IC) Hþ-ATPases also containing B1 and a4 subunits. All types of ICs express CAII.
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In the last set of experiments, kidney sections from healthy
donors were incubated with either serum from the patient (1:200)
or with sera obtained from healthy controls (n¼ 4). Subsequent ad-
dition of anti-human IgG fluorescent labelled antibodies allowed to
detect IgG antibodies. In the kidney sections incubated with con-
trol sera, no IgG-related staining could be detected, whereas the
patient’s serum produced a distinct labelling of the apical pole of a
subset of cells in the collecting duct. Some of these cells were also
positive for AQP2 or AE1, suggesting the presence of autoantibodies
against principal and A-ICs in the patients serum (Figure 3E and F).
DISCUSSION
dRTA can be caused by various autoimmune disorders. While
the relative high incidence of dRTA in patients with Sjo¨gren’s
syndrome or rheumatoid arthritis has been well documented,
far fewer reports are available about the occurrence of dRTA in
patients with PBC [8, 10, 11]. The incidence of dRTA in patients
with renal involvement in Sjo¨gren’s syndrome has been esti-
mated to be up to 30% [6, 19], whereas the incidence of dRTA in
syndromes of PBC is not very well studied. One study including
18 patients with PBC found dRTA in six patients (33%) [11].
Our patient showed the typical clinical symptoms of dRTA,
the combination of normal anion gap hyperchloraemic meta-
bolic acidosis and hypokalaemia with an inappropriately alka-
line urine pH. Moreover, she presented with a positive UAG,
suggesting impaired renal excretion of ammonium.
Her kidney biopsy showed signs of active tubulointerstitial ne-
phritis. However, dRTA is not a typical feature of tubulointerstitial
nephritis and therefore we further analysed the biopsy of the pa-
tient for alterations in the expression of markers of acid-secretory
ICs. Immunohistochemical analysis revealed the complete absence
of three different markers of A-ICs, the AE1 anion exchanger and
the B1 and a4 Hþ-ATPase subunits that are enriched in these cells
[1]. Moreover, all cells lining the connecting tubule and collecting
ducts in the patient’s biopsy stained for the AQP2 water channel, a
marker of PCs. These findings suggest the loss of differentiated ICs
from the kidney of this patient and explain the severity of acidosis.
Absence of Hþ-ATPase staining or even the complete loss of
markers of ICs has been described in few cases of patients with
Sjo¨gren’s syndrome and dRTA [7, 20, 21] or in a patient with au-
toimmune gastritis and hypothyroidism [4]. In a small series of
13 patients with tubulointerstitial nephritis specifically selected
for the presence of a high number of IgM-positive plasma cells
in their kidney biopsies, all patients were reported to suffer
from dRTA. However, also 92% of patients had signs of renal
Fanconi syndrome and four patients were found to have also
Sjo¨gren’s syndrome [22]. Notably, in the biopsies of all patients,
a reduced number of AE1 and E1 Hþ-ATPase subunit-positive
cells were observed. Also, AMA titres were elevated.
Autoantibodies directed against ICs have been identified in
few patients; however, the exact target of these autoantibodies
has remained mostly elusive. In some patients with Sjo¨gren’s
syndrome, the presence of autoantibodies against carbonic an-
hydrase II (CAII) has been reported [23, 24]. In patients with
tubulointerstitial nephritis and a high number of IgM-positive
plasma cells, a role of IgM and anti-mitochondrial antibodies
has been discussed, but no causative role and no targets are
proven yet. Our patient had elevated levels of IgM and increased
titres for anti-mitochondrial antibodies.
We also detected autoantibodies in the serum of our patient,
which appear to be directed against a subset of cells in the collect-
ing duct. Cells positive for AQP2 but also cells that stained for AE1
were stained by autoantibodies, mostly at the apical pole. This
pattern is not consistent with the expression of CAII, which is lo-
calized to the cytosol of all ICs but absent from PCs. It is also not
consistent with the pattern of Hþ-ATPase expression in these
cells or with mitochondrial targets, suggesting that other, as yet
unknown proteins may be targeted by these autoantibodies.
In summary, PBC can be associated with dRTA and may be
considered as a complication in managing PBC patients. dRTA is
likely caused by the absence of A-ICs in the kidney. Autoantibodies
were detected, but whether these autoantibodies are the cause or
consequence of dRTA and tubulointerstitial nephritis is unclear.
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Supplementary data are available at ckj online.
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